Wolfram Döhner

451 total citations
6 papers, 35 citations indexed

About

Wolfram Döhner is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wolfram Döhner has authored 6 papers receiving a total of 35 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Cardiology and Cardiovascular Medicine, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Wolfram Döhner's work include Erythropoietin and Anemia Treatment (2 papers), PARP inhibition in cancer therapy (2 papers) and Stress Responses and Cortisol (1 paper). Wolfram Döhner is often cited by papers focused on Erythropoietin and Anemia Treatment (2 papers), PARP inhibition in cancer therapy (2 papers) and Stress Responses and Cortisol (1 paper). Wolfram Döhner collaborates with scholars based in Germany, Slovakia and Japan. Wolfram Döhner's co-authors include Dirk Habedank, Florian Blaschke, Martin Stockburger, Özlem Özcan Çelebi, Stefan D. Anker, Nicole Ebner, Stephan von Haehling, P. Christian Schulze, Christoph Schöbel and Junichi Ishida and has published in prestigious journals such as International Journal of Cardiology, Journal of Cachexia Sarcopenia and Muscle and Pacing and Clinical Electrophysiology.

In The Last Decade

Wolfram Döhner

5 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfram Döhner Germany 4 16 14 5 5 5 6 35
Cristina Niţă Romania 5 12 0.8× 19 1.4× 9 1.8× 5 1.0× 5 1.0× 16 52
Johannie Gungadoo United Kingdom 2 9 0.6× 11 0.8× 16 3.2× 3 0.6× 2 0.4× 3 42
Selina Begum United Kingdom 4 11 0.7× 5 0.4× 2 0.4× 3 0.6× 10 2.0× 11 25
P. Devillier France 2 9 0.6× 15 1.1× 6 1.2× 2 0.4× 10 2.0× 2 16
Louise Denvir United Kingdom 6 6 0.4× 22 1.6× 15 3.0× 2 0.4× 6 1.2× 11 67
Yu. G. Shvarts Russia 4 25 1.6× 10 0.7× 2 0.4× 2 0.4× 4 0.8× 27 44
Guillermo Godinez United States 4 12 0.8× 13 0.9× 17 3.4× 6 1.2× 32 6.4× 8 68
Gareth Waters United Kingdom 4 8 0.5× 13 0.9× 3 0.6× 11 2.2× 5 42
Elena Kinova Bulgaria 5 20 1.3× 11 0.8× 5 1.0× 2 0.4× 2 0.4× 17 41
L.M. Cano Spain 6 7 0.4× 9 0.6× 7 1.4× 2 0.4× 3 0.6× 7 60

Countries citing papers authored by Wolfram Döhner

Since Specialization
Citations

This map shows the geographic impact of Wolfram Döhner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram Döhner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram Döhner more than expected).

Fields of papers citing papers by Wolfram Döhner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfram Döhner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram Döhner. The network helps show where Wolfram Döhner may publish in the future.

Co-authorship network of co-authors of Wolfram Döhner

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfram Döhner. A scholar is included among the top collaborators of Wolfram Döhner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfram Döhner. Wolfram Döhner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Palus, Sandra, Tanja Braun, Stephan von Haehling, et al.. (2022). The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia. Journal of Cachexia Sarcopenia and Muscle. 13(4). 2202–2210. 3 indexed citations
2.
Bekfani, Tarek, Christoph Schöbel, Miroslava Valentová, et al.. (2020). Heart Failure and Sleep-Disordered Breathing: Susceptibility to Reduced Muscle Strength and Preclinical Congestion (SICA-HF Cohort). ESC Heart Failure. 7(5). 2063–2070. 11 indexed citations
3.
Saitoh, Masakazu, Masaaki Konishi, Junichi Ishida, et al.. (2016). Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia. International Journal of Cardiology. 218. 312–317. 8 indexed citations
4.
Çelebi, Özlem Özcan, et al.. (2012). Extraordinarily Favorable Left Ventricular Reverse Remodeling through Long‐Term Cardiac Resynchronization: Super‐Response to Cardiac Resynchronization. Pacing and Clinical Electrophysiology. 35(7). 870–876. 11 indexed citations
5.
Döhner, Wolfram, Stephan von Haehling, & Stefan D. Anker. (2005). Chronische Herzinsuffizienz - eine metabolische Erkrankung: Von der Pathophysiologie zu neuen Therapieansätzen. 1(1). 45–56.
6.
Döhner, Wolfram, et al.. (1969). [Clinical studies with noxiptilin in long-term hospitalized schizophrenic patients].. PubMed. 19. Suppl 5a:908+–Suppl 5a:908+. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026